Drug efflux by Breast Cancer Resistance Protein (BCRP) is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924

類似資料

• HER receptor signaling confers resistance to the insulin-like growth factor 1 receptor inhibitor, BMS-536924
  著者:: Haluska, Paul, 等
  出版事項: (2008)
• Expression of Insulin Receptor Isoform A and Insulin-Like Growth Factor-1 Receptor in Human Acute Myeloid Leukemia: Effect of the dual receptor inhibitor BMS-536924 in Vitro
  著者:: Hendrickson, Andrea E. Wahner, 等
  出版事項: (2009)
• The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors
  著者:: Huang, Fei, 等
  出版事項: (2009)
• BMS-536924 Reverses IGF-IR-induced Transformation of Mammary Epithelial Cells and Causes Growth Inhibition and Polarization of MCF7 Cells
  著者:: Litzenburger, Beate C., 等
  出版事項: (2009)
• Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression
  著者:: Nakanishi, Takeo, 等
  出版事項: (2012)